US Edition
News from Managed Healthcare Executive
Top Managed Healthcare Executive News
FDA · EmporiaThe approval builds upon concizumab’s previous December 2024 clearance and allows for treatment in patients with hemophilia A or B, both with or without inhibitors.See the Story
FDA Expands Approval of Concizumab-Mtci to Include Hemophilia A, B Without Inhibitor Use
66% Center coverage: 24 sources
Business · United StatesThe FDA granted accelerated approved to zongertinib as the first oral treatment for adults with unresectable or metastatic HER2-mutant non-squamous non-small cell lung cancer, according to press release from Boehringer Ingelheim.See the Story
FDA Approves Hernexeos as First Oral Therapy for NSCLC with HER2 Mutations
67% Left coverage: 12 sources
Amarillo · AmarilloAMARILLO, Texas, Aug. 13, 2025 /PRNewswire/ -- Maxor Specialty Pharmacy, a VytlOne company, was selected by Insmed to be a limited distribution provider of Brinsupri™. Brinsupri is a dipeptidyl peptidase 1 (DPP1) inhibitor indicated for the treatment of non-cystic fibrosis…See the Story
VytlOne Announces New Partnership with Insmed
100% Center coverage: 11 sources
